On June 5, 2025, Martin Maxwell, a Director at Integer Holdings Corp (ITGR, Financial), sold 8,720 shares of the company. Following this transaction, the insider now owns 22,170 shares of Integer Holdings Corp.
Integer Holdings Corp (ITGR) is a medical device outsource manufacturer that provides innovative, high-quality medical technologies to its customers. The company operates in various segments, including Advanced Surgical, Orthopedics & Portable Medical, Cardio & Vascular, and Cardiac Rhythm Management & Neuromodulation.
Over the past year, Martin Maxwell has sold a total of 13,420 shares and has not purchased any shares. The insider transaction history for Integer Holdings Corp indicates that there have been no insider buys in the past year, while there have been six insider sells during the same period.
On the day of the recent sale, shares of Integer Holdings Corp were trading at $120.56, giving the stock a market cap of $4.233 billion. The company's price-earnings ratio stands at 57.50, which is higher than the industry median of 27.915 and also higher than the company’s historical median price-earnings ratio.
With a trading price of $120.56 and a GF Value of $108.04, Integer Holdings Corp has a price-to-GF-Value ratio of 1.12, indicating that the stock is modestly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples, a GuruFocus adjustment factor, and future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
